Elidah

Executive Summary

Elidah is a US-based medical device company dedicated to women's health, specifically addressing pelvic floor disorders such as stress urinary incontinence (SUI) and overactive bladder (OAB). Founded in 2018, the company developed ELITONE, a non-invasive, at-home therapy device that delivers clinical-grade treatment by stimulating pelvic floor muscles. ELITONE offers an alternative to invasive surgeries or cumbersome Kegel exercises, targeting the root cause of bladder leaks. With millions of women suffering from these conditions, Elidah addresses a large and underserved market. The device is already commercially available, and the company has established a direct-to-consumer sales channel, though detailed financial traction and funding history are not disclosed.

Upcoming Catalysts (preview)

• Q3 2026Pivotal clinical trial results for ELITONE in treating overactive bladder70% success
• Q2 2026Strategic partnership with a major healthcare system or insurer for distribution50% success
• H2 2026Series B funding round to support commercialization and product expansion60% success